1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands
摘要:
Novel 1-(2-aminoethyl)-3-(arylsulfonyl)-1H-indoles were prepared. Binding assays indicated they are 5-HT6 receptor ligands, among which N,N-dimethyl-N-{2-[3-(1-naphthylsulfonyl)-1H-indol-1-yl]ethyl}amine 8t and N-methyl-N-{2-[3-(1-naphthylsulfonyl)-1H-indol-1-yl]ethyl}amine 8u showed high affinity for 5-HT6 receptors with K-i = 3.7 and 5.7nM, respectively. (C) 2004 Elsevier Ltd. All rights reserved.
1-(AMINOALKYL)-3-SULFONYLINDOLE AND-INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:US20030232828A1
公开(公告)日:2003-12-18
The present invention provides compounds of formula I and the use thereof for the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor.
1
本发明提供了化合物I的公式以及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。
1-(AMINOALKYL)-3-SULFONYLINDOLE AND -INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:EP1509501A1
公开(公告)日:2005-03-02
US6727246B2
申请人:——
公开号:US6727246B2
公开(公告)日:2004-04-27
[EN] 1-(AMINOALKYL)-3-SULFONYLINDOLE AND -INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS<br/>[FR] DERIVES DE 1-(AMINOALKYL)-3-SULFONYLINDOLE ET -INDAZOLE COMME LIGANDS 5-HYDROXYTRYPTAMINE-6
申请人:WYETH CORP
公开号:WO2003101962A1
公开(公告)日:2003-12-11
The present invention provides compounds of formula (I) and the use thereof for the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor.
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands
作者:Ronald Bernotas、Steven Lenicek、Schuyler Antane、Guo Ming Zhang、Deborah Smith、Joseph Coupet、Boyd Harrison、Lee E. Schechter
DOI:10.1016/j.bmcl.2004.09.003
日期:2004.11
Novel 1-(2-aminoethyl)-3-(arylsulfonyl)-1H-indoles were prepared. Binding assays indicated they are 5-HT6 receptor ligands, among which N,N-dimethyl-N-2-[3-(1-naphthylsulfonyl)-1H-indol-1-yl]ethyl}amine 8t and N-methyl-N-2-[3-(1-naphthylsulfonyl)-1H-indol-1-yl]ethyl}amine 8u showed high affinity for 5-HT6 receptors with K-i = 3.7 and 5.7nM, respectively. (C) 2004 Elsevier Ltd. All rights reserved.